Marijuana Business Magazine October 2019

Marijuana Business Magazine | October 2019 58 M uch of the medical marijua- na industry’s future success depends on how seriously the medical community takes the concept of cannabinoids as medicine, and in which form—either as a treatment approved by the U.S. Food and Drug Administration, or one not FDA-approved. By most accounts, physician acceptance and awareness of medical cannabis is growing. But it remains far from the norm. Recent headlines suggest that small numbers of doctors in new markets such as Louisiana and Missouri have signed up to recommend MMJ to patients, thereby slowing market growth. Also, many physician groups remain unequiv- ocally opposed to medical and recre- ational legalization. Delegates to the 2018 annual meeting of the American Medical Association (AMA), the largest physicians’ group in the United States, approved a resolution stating “that cannabis for medicinal use should not be legalized through the state legislative, ballot initiative, or referendum process.” The Physician Doctors will play a key role in determining the future of medical cannabis in the United States Factor By Omar Sacirbey A NewKind of Medical